ClinicalTrials.Veeva

Menu

Grid Laser for Diffuse Diabetic Maculopathy (MMG)

D

Dow University of Health Sciences

Status

Completed

Conditions

Diabetic Macular Edema

Study type

Observational

Funder types

Other

Identifiers

NCT02555956
Macular Grid Laser

Details and patient eligibility

About

Diabetic related complications are increasing day by day due to increse in the number of diabetic patients all over the world. Diabetic macular edema is one of them and a major cause of vision imparment. Various kind of treatment modalities are preent to treat this coplication. Grid laser is one treatment modality. Laser phtocoagulation is a destrictive procedure.Laser power if kept to aminimum can get the desired results without severe destruction to the retina . In this study, the investigators are going to document the effect of minimal grid laser tn loss o overcome the visioe to diabetic macular edema.

Enrollment

50 patients

Sex

All

Ages

20 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diabetic patients with macular edema.
  • both sexes
  • conset to participate.

Exclusion criteria

  • focal edema.
  • patients requiring only the focal laser.
  • patients with proferative diabetic retinopathy.
  • Patients with ischaemic maculopathy on fundus fluorescein angiography.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems